MedTrace Logo

A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male Volunteers

NCT03378284 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2018-03-30

No results posted yet for this study

Summary

A randomized, open-label, active-controlled, multiple dose phase 1 clinical trial to evaluate safety, tolerability, and pharmacodynamics of tegoprazan after oral administration in healthy male volunteers

Conditions

  • Pharmacodynamics
  • Healthy Male Volunteers

Interventions

DRUG

Tegoprazan

Tegoprazan QD for 7 days

DRUG

Revaprazan

Revaprazan QD for 7 days

Sponsors & Collaborators

  • HK inno.N Corporation

    lead INDUSTRY

Principal Investigators

  • In Jin Jang, MD, PhD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-10
Primary Completion
2017-12-23
Completion
2018-01-16

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03378284 on ClinicalTrials.gov